Sermonix Pharmaceuticals, LLC
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Nov 2021 | $40 M | No. 3 | $10 to $50 million | equity | SEC | |
| Jul 2016 | $2 M | No. 2 | Under $2 million | equity | SEC | |
| Sep 2015 | $1 M | No. 1 | Under $2 million | debt, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Sermonix Pharmaceuticals, LLC chose not to state its revenue in its newest notice of a funding round (Nov 2021).
SEC Form D · Nov 2021
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Nov 2021
That is all the official record says: Sermonix Pharmaceuticals, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Sermonix Pharmaceuticals, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 17 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Anthony Wild | Executive officer | Nov 2021 |
| Barry Komm | Executive officer | Nov 2021 |
| David Portman | Executive officer | Nov 2021 |
| Elizabeth Attias | Executive officer | Nov 2021 |
| Miriam Portman | Executive officer | Nov 2021 |
| Paul Plourde | Executive officer | Nov 2021 |
| Simon Jenkins | Executive officer | Nov 2021 |
| Anthony Wild | Director | Nov 2021 |
| David Portman | Director | Nov 2021 |
| Elizabeth Garner | Director | Nov 2021 |
| Michael Friedman | Director | Nov 2021 |
| Richard De Schutter | Director | Nov 2021 |
| Thomas Pfisterer | Director | Nov 2021 |
| Miriam Portman | Director | Jul 2016 |
| Patrick Wiesel | Director | Jul 2016 |
| David Portman | Promoter | Nov 2021 |
| Miriam Portman | Promoter | Nov 2021 |